What is StemRad?
StemRad is at the forefront of developing advanced radiation protection solutions, most notably its Radiation Shield technology. This innovative product is engineered to provide targeted shielding for vital organs, mitigating the risks associated with harmful radiation exposure. The company's clientele spans critical professions including firefighters, military personnel, medical crews, astronauts, and civilians who face potential radiation hazards. StemRad's scientific advancements are designed to enhance user safety and mobility during high-risk operations, aiming to improve survival rates from acute radiation doses and reduce long-term cancer risks.
How much funding has StemRad raised?
StemRad has raised a total of $6M across 1 funding round:
Series C
$6M
Series C (2017): $6M, investors not publicly disclosed
What's next for StemRad?
The recent major strategic investment signifies a pivotal moment for StemRad, likely enabling the company to scale its operations, expand its product reach, and further its research and development in radiation mitigation technologies. This capital infusion is expected to accelerate market penetration and solidify StemRad's position as a leader in personal radiation safety, particularly for high-risk industries and space exploration.
See full StemRad company page
